IMV Inc  Launches Plans to Advance Clinical Development of a Vaccine Candidate Against COVID 19,DARTMOUTH  Nova Scotia BUSINESS WIRE IMV Inc   Nasdaq  IMV  TSX  IMV  a clinical stage biopharmaceutical company  the Company or IMV  today announced that it is advancing the clinical development of a DPX based vaccine candidate against COVID 19  Va,DARTMOUTH  Nova Scotia BUSINESS WIRE IMV Inc   Nasdaq  IMV  TSX  IMV  a clinical stage biopharmaceutical company  the Company or IMV  today announced that it is advancing the clinical development of a DPX based vaccine candidate against COVID 19  Vaccin  9189 chars 
